← Stocks · BIAF record
Signal record & history · Trifecta Signals
bioAffinity has been flagged by the Trifecta screener 1 time since 2025. 1 signal confirmed; the median confirmed signal is down 93.3% since its Early Signal.
Price refreshes every trading day after the close.
Full interactive chart ↗ · partner link
Daily closes · through the most recent close
Price history from Jan 2018 · Signal tracking began Jan 2022
Headline statistics: confirmed signals only, measured from the confirmation price.
First signal Oct 2025 · Latest Oct 2025 · Confirmed 1 of 1 Early · Latest close in the chart data: Thu, Nov 5, 2026
Groups are mutually exclusive — every confirmed signal sits in exactly one.
Since October 2025, bioAffinity has had one Early signal, one confirmed. Its one decided signal gained +10% within 90 days, and it did not finish ahead of the S&P 500 since confirmation.
Every Early signal in the record, newest first.
Members see every signal below, and the group mix above.
Membership unlocks the complete signal timeline for BIAF and every other stock in the record — group tags, caution flags, and the full screener.
Already a member? Sign in and this page unlocks.
bioAffinity Technologies sits in the Healthcare sector, in the Diagnostics & Research industry. At a market value of about $5.8 million, it sits in the small-cap group.
The strongest run on bioAffinity Technologies’ record followed a confirmation in October 2025, falling about 50% over the following 90 days. Classification adds texture: its latest signal was rated Low Quality, revenue was growing by about 5.0% at the time, and it sat in the small-cap group when that signal fired.
BIAF closed Thursday, November 5 at $2.60, down 11.3% on the day. The last five sessions span about $2.60 to about $3.19.
